학술논문
Healthcare antitrust in the US: high stakes and uncertain bounds
Document Type
Journal Article
Author
Source
G.C.R. 2004, 7(3) Supp (The Antitrust Review of the Americas 2004), 59-63
Subject
Language
English
ISSN
1369-4561
Abstract
Discusses the application of US competition law to health care providers. Considers: (1) the extent to which collaborations among providers are unlawful; and (2) abuses by the pharmaceutical industry, including agreements between brand and generic manufacturers, and unilateral conduct by brand companies.